(2023). The Effect of Topical Timolol 0.5% Solution on the Healing of Postoperative Anal and Perianal Wounds; a Randomized Controlled Trial. The Egyptian Journal of Hospital Medicine, 93(1), 7376-7381. doi: 10.21608/ejhm.2023.324582
. "The Effect of Topical Timolol 0.5% Solution on the Healing of Postoperative Anal and Perianal Wounds; a Randomized Controlled Trial". The Egyptian Journal of Hospital Medicine, 93, 1, 2023, 7376-7381. doi: 10.21608/ejhm.2023.324582
(2023). 'The Effect of Topical Timolol 0.5% Solution on the Healing of Postoperative Anal and Perianal Wounds; a Randomized Controlled Trial', The Egyptian Journal of Hospital Medicine, 93(1), pp. 7376-7381. doi: 10.21608/ejhm.2023.324582
The Effect of Topical Timolol 0.5% Solution on the Healing of Postoperative Anal and Perianal Wounds; a Randomized Controlled Trial. The Egyptian Journal of Hospital Medicine, 2023; 93(1): 7376-7381. doi: 10.21608/ejhm.2023.324582
The Effect of Topical Timolol 0.5% Solution on the Healing of Postoperative Anal and Perianal Wounds; a Randomized Controlled Trial
Background: Wound healing after anal surgery remains a challenging problem. May topical agents have been used to deal with this problem with variable results? Topical timolol was used successfully in the management of chronic and refractory wounds. Aim: This study aimed to assess the effect of topical timolol 0.5% solution on healing of postoperative anal and perianal wounds. Patients and methods: 70 participants with anal and perianal wounds were enrolled in this randomized controlled trial. Patients were randomized into two equal groups (35 in each): The timolol group where patients were treated with topical timolol maleate 0.5% solution. The control group wher patients were treated with normal saline solution. Results: Preoperative patients’ characteristics and Quality of life (QoL) were comparable between the two groups. Regarding the % of healing at postoperative 1 month, outcome data showed that there were no significant results (75.7 ± 6 % vs 75.2 ± 10.4 %, P=0.81) and healing time (6.2 ± 2.3 vs 5.9 ± 1.7 weeks, P=0.54) between the timolol and control groups respectively. Despite the significant improvement in QoL at postoperative 6 months in both groups, non-statistical significant differences were found between both groups regarding postoperative QoL scores at 1, 3, and 6 months. Pain assessment and complications were comparable between both groups and all complications were managed successfully. Conclusion: Topical timolol 0.5% solution showed no significant advantage over routine postoperative wound care in the case of anal surgical wounds. Further studies using different forms, doses, and concentrations are required.
View on SCiNiTO
Top